Hepatic sEH-Nrf2 Axis Regulates Osteoclastogenesis in Osteop
2026-05-28
This study uncovers a novel liver-bone regulatory mechanism in osteoporosis, showing that hepatic soluble epoxide hydrolase (sEH) promotes osteoclast differentiation by suppressing the Nrf2 signaling pathway. These findings offer new mechanistic insights into redox imbalance and suggest future targets for signaling pathway modulation in bone disease research.
Advanced In Vitro Metrics Refine Anticancer Drug Evaluation
2026-05-27
Schwartz’s dissertation introduces a rigorous framework for dissecting drug responses in cancer cell models by distinguishing growth inhibition from cell death, enabling more informative preclinical assessments. This approach clarifies the limitations of standard viability measures and suggests actionable improvements for anticancer compound evaluation.
Hexetidine (NSC-17764): Biofilm Resistance and Translational
2026-05-27
Explore how Hexetidine (NSC-17764) confronts the challenge of biofilm-associated antimicrobial resistance, drawing on pivotal mechanistic research and practical assay guidance. This article provides a unique, in-depth analysis of its implications for oral infection models and device-associated biofilms.
Dual Glutamate Receptor Blockade for Soman-Induced Neuroprot
2026-05-26
This study demonstrates that IEM-1925, a dual AMPA/NMDA receptor antagonist, provides robust antiseizure, neuroprotective, and cognitive benefits following soman-induced status epilepticus in rats. The findings support glutamate receptor blockade as a promising strategy for mitigating organophosphorus nerve agent neurotoxicity and highlight the translational potential of selective AMPA receptor blockers in neuroprotection research.
MG-132 (SKU A2585): Reliable Proteasome Inhibition in Cancer
2026-05-26
This article addresses critical workflow challenges in cell viability and apoptosis assays, highlighting how MG-132 (SKU A2585) delivers reproducible, quantitative solutions for cancer research. Drawing on scenario-driven Q&A and peer-reviewed evidence, it guides researchers in optimizing experimental design, protocol execution, and data interpretation using MG-132.
Sulfaphenazole: Redefining CYP2C9 Inhibition for Tissue Repa
2026-05-26
Explore Sulfaphenazole as a potent CYP2C9 inhibitor in vascular tissue repair and wound healing. This article provides new insights into its mechanistic impact on ischemia-reperfusion injury, bridging cytochrome P450 research and translational therapeutics.
PP2A-Regulated Autophagy Drives Candida albicans Biofilm Res
2026-05-25
This study reveals how protein phosphatase 2A (PP2A) modulates autophagy via ATG protein phosphorylation, directly influencing biofilm formation and antifungal drug resistance in Candida albicans. These findings highlight autophagy-related pathways as promising targets for overcoming biofilm-associated resistance, with practical relevance for antifungal susceptibility testing and infection modeling.
Bradford Protein Assay Kit: Practical Guidance for Researche
2026-05-24
The Bradford Protein Assay Kit (SKU K4103) addresses the need for rapid, sensitive, and accurate protein concentration measurement in routine biochemical workflows. It is well-suited for molecular biology, protein purification, and enzymology, but should be avoided with samples containing interfering substances like strong detergents or high salt content.
EPZ-6438: EZH2 Inhibitor Workflows for Advanced Cancer Model
2026-05-23
EPZ-6438 stands out as a potent, selective EZH2 inhibitor, driving reproducible results in epigenetic cancer research from cell-based assays to in vivo tumor models. This guide delivers actionable protocol enhancements, troubleshooting strategies, and cutting-edge use-case insights grounded in recent combinatorial therapy breakthroughs.
MCC950 Sodium in Inflammatory Disease Research: Advanced Pro
2026-05-22
MCC950 sodium (CRID3 sodium salt) stands out as the benchmark for selective NLRP3 inflammasome inhibition, enabling precision studies in inflammatory and autoimmune disease models. This article bridges reference-driven insights with workflow enhancements and troubleshooting guidance, empowering researchers to achieve reproducible, high-impact results.
CHIR 99021 Trihydrochloride: GSK-3 Inhibitor for Organoid Co
2026-05-22
CHIR 99021 trihydrochloride, a premier GSK-3 inhibitor, empowers researchers to finely tune self-renewal and differentiation in stem cell and organoid systems, unlocking new experimental versatility. This article translates breakthrough findings into actionable protocols and troubleshooting strategies, ensuring high reproducibility and depth in metabolic and disease modeling.
Optimizing Workflows with the 7-AAD Cell Viability Assay Kit
2026-05-21
The 7-AAD Cell Viability Assay Kit offers precise necrosis and late apoptosis detection with minimal spectral overlap, enabling high-content multiplexing in flow cytometry and microscopy. This guide translates structural insights from CAR-T research into actionable protocols, advanced applications, and troubleshooting strategies for maximizing assay reliability and data quality.
(S)-(+)-Ibuprofen: Precision COX Inhibitor Workflows in Rese
2026-05-21
(S)-(+)-Ibuprofen delivers unmatched reproducibility and selectivity for COX inhibition, empowering robust inflammation pathway and pain mechanism studies. This article outlines advanced experimental workflows, troubleshooting strategies, and protocol parameters that enable data-driven research with APExBIO’s high-purity standard.
RBMS1 Loss Enables PD-L1 Blockade in Triple-Negative Breast
2026-05-20
The reference study identifies RBMS1 as a key regulator of PD-L1 stability in triple-negative breast cancer (TNBC). Loss of RBMS1 destabilizes PD-L1 through impaired glycosylation, enabling more effective immune checkpoint blockade and providing a mechanistic basis for new immunotherapy strategies.
Sodium Ascorbate: Optimizing ROS-Mediated Tumor Cell Death M
2026-05-20
Sodium Ascorbate, the bioavailable mineral salt of ascorbic acid, is redefining cancer research with its robust induction of intracellular ROS and selective necrotic tumor cell death. This article explores advanced workflows, troubleshooting strategies, and evidence-backed protocol enhancements that position APExBIO’s Sodium Ascorbate as a precision tool for glioblastoma and broader oncologic studies.
457 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page